Petauri Acquires Bluprint Oncology, Cogency, Verascity and Blendworks from Brightly Network
August 14, 2024
Petauri, the Oak Hill Capital–backed pharmaceutical services platform, acquired four U.S.-based medical communications agencies — Bluprint Oncology, Cogency, Verascity, and Blendworks — from the Brightly Network. The additions expand Petauri Advance's oncology, hematology and rare-disease communications capabilities and increase the platform's depth in medical and commercial strategy, engagement, and education.
- Buyers
- Petauri, Oak Hill Capital
- Targets
- Bluprint Oncology, Cogency, Verascity, Blendworks
- Sellers
- Brightly Network
- Platforms
- Petauri Advance
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Petauri Acquires Formulary Insights
November 13, 2024
Healthcare Services
Petauri, a PE‑backed pharmaceutical services platform based in Nashville, has acquired Formulary Insights and merged the business into Petauri Advisors to expand its market access research and strategy capabilities. The acquisition broadens Petauri’s payer and market access offerings for biopharmaceutical clients and is supported by Oak Hill Capital, which is backing the platform with a multi‑hundred million dollar commitment.
-
Petauri Acquires FORCE Communications
February 14, 2024
Healthcare Services
Petauri, a pharmaceutical services platform backed by Oak Hill Capital, has acquired FORCE Communications and its three independent agencies — DRIVE, MOMENTUM, and PROPEL. The add-on expands Petauri's scientific communications and medical education capabilities as the platform continues to build scale in medical affairs, market access, patient services, and data and analytics.
-
Versiti Acquires Pearl Pathways
November 7, 2023
Healthcare Services
Versiti, a Milwaukee-based blood health organization, has acquired Pearl Pathways, an Indianapolis-area life science consulting firm that provides regulatory affairs, quality compliance, CRO services and an independent IRB. The acquisition expands Versiti's clinical trial and life-sciences service capabilities, enabling earlier and deeper support for product development across biopharmaceutical, medical device, and diagnostics clients.
-
Petauri Health (Oak Hill) Acquires The Kinetix Group
June 13, 2023
Healthcare Services
Petauri Health, a pharmaceutical commercialization platform formed by Oak Hill Capital, has acquired The Kinetix Group (TKG), a New York–based market access, access marketing, and medical affairs agency. The Kinetix founders will remain in leadership roles as TKG becomes the inaugural add-on to the Petauri platform, expanding the platform's market access, medical affairs, and real-world evidence capabilities.
-
Contegix Acquires Blended Perspectives
December 8, 2022
IT Services
Contegix, an Atlassian Platinum Solutions Partner based in Virginia, has acquired Blended Perspectives, a Toronto-based Atlassian Platinum Solutions Partner known for its Marketplace Analytics Research Service (MARS). Financing for the transaction was provided by Tree Line Capital Partners to support the deal and expand Contegix's Atlassian consulting capabilities and marketplace analytics offerings across North America.
-
Amplity Health Acquires The Lynx Group
January 4, 2022
Healthcare Services
Amplity Health, a portfolio company of Altamont Capital Partners, has merged with The Lynx Group, an oncology-focused medical communications firm, expanding Amplity’s medical communications and market access capabilities. The Lynx Group CEO Brian F. Tyburski joins Amplity as EVP, Sales and Operations; terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.